New roles of HDL in inflammation and hematopoiesis

Annual Review of Nutrition

Volumn 32, Issue , 2012, Pages 161-182

  Zhu, Xuewei ^a   Parks, John S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ABC transporter; Cholesterol; Hematopoietic stem cell; High density lipoprotein; Lipid raft

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; FREE CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

CELL MEMBRANE; CHOLESTEROL TRANSPORT; HEMATOPOIESIS; HUMAN; INFLAMMATION; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT; REVIEW;

ANIMALS; APOLIPOPROTEIN A-I; CARDIOVASCULAR DISEASES; CELL PROLIFERATION; CHOLESTEROL; ENDOTHELIUM, VASCULAR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LIPOPROTEINS, HDL; LYMPHOCYTES; MEMBRANE MICRODOMAINS;

BACTERIA (MICROORGANISMS);

EID: 84864245295     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071811-150709     Document Type: Review

References (129)

1. Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, et al. 2011. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim. Biophys. Acta 1721:405-15
2. Angeli V, Llodra J, Rong JX, Satoh K, Ishii S, et al. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561-74 (Pubitemid 39370511)
3. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC. 2010. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J. Immunol. 184:173-83
4. Attie AD, Kastelein JP, Hayden MR. 2001. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42:1717-26 (Pubitemid 33116703)
5. Baldan A, Gomes AV, Ping P, Edwards PA. 2008. Loss of ABCG1 results in chronic pulmonary inflammation. J. Immunol. 180:3560-68
6. Bates SR, Tao JQ, Collins HL, Francone OL, Rothblat GH. 2005. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 289:L980-89 (Pubitemid 41681333)
7. Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, et al. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96:2170-79
8. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, et al. 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97-111 (Pubitemid 351905740)
9. Bensinger SJ, Tontonoz P. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454:470-77
10. BirjmohunRS, Vergeer M, Stroes ES, SandhuMS, Ricketts SL, et al. 2009. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study. PLoS One 4:e6809
11. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:347-5112
12. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-45 (Pubitemid 29369523)
13. Calabresi L, Franceschini G, Sirtori CR, De Palma A, Saresella M, et al. 1997. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem. Biophys. Res. Commun. 238:61-65 (Pubitemid 27453274)
14. Calkin AC, Tontonoz P. 2010. Liver X receptor signaling pathways and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30:1513-18
15. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, DuongDN, et al. 2009. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119:1871-79
16. Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278:10443-49 (Pubitemid 36800310)
17. Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, et al. 2003. Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12:805-16 (Pubitemid 37352775)
18. Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, et al. 2011. Endotheliumprotective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. USA 108:9613-18
19. Clee SM, Kastelein JJ, vanDM, Marcil M, RoompK, et al. 2000. Age and residual cholesterol efflux affect HDLcholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest. 106:1263-70
20. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15:1987-94
21. Davidson WS, Silva RAG, Chantepie S, Lagor WR, Chapman MJ, Kontush A. 2009. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters. Arterioscler. Thromb. Vasc. Biol. 29:870-76
22. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. 2010. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar highdensity lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler. Thromb. Vasc. Biol. 30:796-801
23. Devries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, et al. 2005. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171:61-73 (Pubitemid 41434602)
24. Di Bartolo BA, Nicholls SJ, Bao S, Rye KA, Heather AK, et al. 2011. The apolipoprotein A-I mimetic peptideETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis 217:395-400
25. Dixit VD. 2010. Thymic fatness and approaches to enhance thymopoietic fitness in aging. Curr. Opin. Lipidol. 22:521-28
26. Dorshkind K, Montecino-Rodriguez E, Signer RA. 2009. The ageing immune system: Is it ever too old to become young again? Nat. Rev. Immunol. 9:57-62
27. Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, et al. 1997. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas-identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272:25576-82 (Pubitemid 27438869)
28. Duewell P, KonoH, RaynerKJ, Sirois CM, Vladimer G, et al. 2010.NLRP3inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357-61
29. Eisenberg S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25:1017-58
30. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, et al. 2003. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5:781-92 (Pubitemid 37087166)
31. Fessler MB, Parks JS. 2011. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187:1529-35
32. Fielding CJ, Fielding PE. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:211-2833.
33. Francone OL, Royer L, Boucher G, Haghpassand M, Freeman A, et al. 2005. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler. Thromb. Vasc. Biol. 25:1198-205 (Pubitemid 40776609)
34. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. 2010. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841-45
35. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, et al. 2007. Parallel SUMOylation-dependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25:57-70 36. Goldstein JL, DeBose-Boyd RA, BrownMS. 2006. Protein sensors formembrane sterols. Cell 124:35-46
36. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, et al. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15 (Pubitemid 19043669)
37. Heller M, Schlappritzi E, Stalder D, Nuoffer JM, Haeberli A. 2007. Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring. Mol. Cell. Proteomics 6:1059-72 (Pubitemid 47019407)
38. Hinrichs JW, Klappe K, Hummel I, Kok JW. 2004. ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J. Biol. Chem. 279:5734-38 (Pubitemid 38220603)
39. Holland AM, van den Brink MR. 2009. Rejuvenation of the aging T cell compartment. Curr. Opin. Immunol. 21:454-59
40. Hortin GL, Shen RF, Martin BM, Remaley AT. 2006. Diverse range of small peptides associated with high-density lipoprotein. Biochem. Biophys. Res. Commun. 340:909-15 (Pubitemid 43053915)
41. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-31 (Pubitemid 26360651)
42. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, et al. 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309 (Pubitemid 39360910)
43. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9:213-19 (Pubitemid 36227724)
44. Kay JG, Murray RZ, Pagan JK, Stow JL. 2006. Cytokine secretion via cholesterol-rich lipid raftassociated SNAREs at the phagocytic cup. J. Biol. Chem. 281:11949-54 (Pubitemid 43855458)
45. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, et al. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1:121-31 (Pubitemid 43977167)
46. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, et al. 2011. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364:127-35
47. Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, et al. 2006. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J. Biol. Chem. 281:37457-67 (Pubitemid 46042049)
48. Kimura T, Tomura H, Mogi C, Kuwabara A, IshiwaraM, et al. 2006. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal. 18:841-50 (Pubitemid 43208937)
49. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. 2003. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44:2339-48 (Pubitemid 38082492)
50. Landry YD, DenisM, Nandi S, Bell S, Vaughan AM, Zha X. 2006. ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J. Biol. Chem. 281:36091-101 (Pubitemid 46041342)
51. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, et al. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272:3137-40 (Pubitemid 27066798)
52. Levels J, Geurts P, Karlsson H, Maree R, Ljunggren S, et al. 2011. High-density lipoprotein proteome dynamics in human endotoxemia. Proteome Sci. 9:34
53. Li Y, Schwabe RF, Devries-Seimon T, Yao PM, Gerbod-Giannone MC, et al. 2005. Free cholesterolloaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB-and MAP kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280:21763-72 (Pubitemid 40827824)
54. Linton MF, Atkinson JB, Fazio S. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267:1034-37
55. Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, et al. 2006. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J. Biol. Chem. 281:32197-206 (Pubitemid 46036774)
56. Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF. 2001. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J. Biol. Chem. 276:3158-66
57. Mineo C, Deguchi H, Griffin JH, Shaul PW. 2006. Endothelial and antithrombotic actions of HDL. Circ. Res. 98:1352-64 (Pubitemid 43948059)
58. Mulya A, Seo J, Brown AL, Gebre AK, Boudyguina E, et al. 2010. ApolipoproteinMexpression increases the size of nascent pre betaHDLformed by ATP binding cassette transporter A1. J. Lipid Res. 51:514-24
59. Murata N, Sato K, Kon J, Tomura H, Yanagita M, et al. 2000. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352(Pt. 3):809-15 (Pubitemid 32015038)
60. Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, et al. 2011. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 121:4138-49
61. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, et al. 2008. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28:2071-77
62. Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, et al. 2011. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler. Thromb. Vasc. Biol. 31:1333-41
63. Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR. 2012. Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. Biochim. Biophys. Acta 1821:513-21
64. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, et al. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328:1566-69
65. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, et al. 2002. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105:290-92 (Pubitemid 34106174)
66. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. 2005. The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 38:153-63 (Pubitemid 39656127)
67. Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, et al. 2005. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111:1543-50 (Pubitemid 40470651)
68. Nissen SE, Tsunoda T, TuzcuEM, Schoenhagen P, CooperCJ, et al. 2003. Effect of recombinantApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA 290:2292-300 (Pubitemid 37430562)
69. Noto H, Hara M, Karasawa K, Iso O, Satoh H, et al. 2003. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23:829-35 (Pubitemid 36566173)
70. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, et al. 2005. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122:707-21 (Pubitemid 41242636)
71. Olsson S, Sundler R. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol. Immunol. 43:607-12 (Pubitemid 41785388)
72. Oram JF, Lawn RM. 2001. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 42:1173-79 (Pubitemid 32744239)
73. Ou J, Wang J, Xu H, Ou Z, Sorci-Thomas MG, et al. 2005. Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet. Circ. Res. 97:1190-97
74. Out R, Hoekstra M, Habets K, Meurs I, de Waard V, et al. 2008. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 28:258-64 (Pubitemid 351161197)
75. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Perez-Morga D. 2006. The trypanolytic factor of human serum. Nat. Rev. Microbiol. 4:477-86 (Pubitemid 43771867)
76. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, et al. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704 (Pubitemid 28257577)
77. Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, et al. 2005. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309:469-72 (Pubitemid 40994686)
78. Pike LJ. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44:655-67 (Pubitemid 37279667)
79. Puff N, Lamaziere A, SeigneuretM, Trugnan G, Angelova MI. 2005.HDLsinduce raft domain vanishing in heterogeneous giant vesicles. Chem. Phys. Lipids 133:195-202 (Pubitemid 40092118)
80. Quarck R, De Geest B, Stengel D, Mertens A, Lox M, et al. 2001. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation 103:2495-500 (Pubitemid 32493377)
81. Quinet EM, Basso MD, Halpern AR, Yates DW, Steffan RJ, et al. 2009. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J. Lipid Res. 50:2358-70
82. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, et al. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5:e11765
83. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, et al. 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478:404-7
84. Rayner KJ, Su?arez Y, D?avalos A, Parathath S, Fitzgerald ML, et al. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570-73
85. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. 2002. Regulation of ATPbinding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277:18793-800 (Pubitemid 34952438)
86. Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JCM. 2006. Proteomic analysis of high-density lipoprotein. Proteomics 6:721-30 (Pubitemid 43208050)
87. Rosenblat M, Volkova N, Ward J, Aviram M. 2011. Paraoxonase 1 (PON1) inhibits monocyte-tomacrophage differentiation. Atherosclerosis 219:49-56
88. Rozenberg O, Howell A, AviramM. 2006. Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis 188:68-76 (Pubitemid 44142537)
89. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. 2003. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med. 34:774-84 (Pubitemid 36288542)
90. Rust S, Rosier M, Funke H, Real J, Amoura Z, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:352-55 (Pubitemid 29369525)
91. SamanovicM, Molina-PortelaMP, Chessler AD, Burleigh BA, Raper J. 2009. Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog. 5:e1000276
92. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, et al. 2008. Infusion of reconstituted highdensity lipoprotein leads to acute changes in human atherosclerotic plaque. Circ. Res. 103:1084-91
93. Shih DM, Gu L, Xia YR, NavabM, LiWF, et al. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-87 (Pubitemid 28335041)
94. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, et al. 2000. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem. 275:17527-35 (Pubitemid 30430794)
95. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39
96. SmoakKA, Aloor JJ, Madenspacher J, Merrick BA, Collins JB, et al. 2010. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 11:493-502
97. Sun Y, Ishibashi M, Seimon T, Lee M, Sharma SM, et al. 2009. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ. Res. 104:455-65
98. Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, et al. 2010. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122:1919-27
99. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. 2009. Themacrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 284:32336-43
100. Tang C, Vaughan AM, Anantharamaiah GM, Oram JF. 2006. Janus kinase 2 modulates the lipidremoving but not protein-stabilizing interactions of amphipathic helices with ABCA1. J. Lipid Res. 47:107-14 (Pubitemid 43107454)
101. Theilmeier G, De Geest B, Van Veldhoven PP, Stengel D, Michiels C, et al. 2000. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/-mice. FASEB J. 14:2032-39
102. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-53
103. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115:2603-11 (Pubitemid 34778077)
104. Tward A, Xia YR, Wang XP, Shi YS, Park C, et al. 2002. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106:484-90 (Pubitemid 34803695)
105. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ. 2000. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J. Biol. Chem. 275:11278-83 (Pubitemid 30212775)
106. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, et al. 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties ofHDL. J. Clin. Invest. 117:746-56 (Pubitemid 46348533)
107. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK. 2004. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. USA 101:17813-18 (Pubitemid 40051969)
108. van der Velde AE, Brufau G, Groen AK. 2010. Transintestinal cholesterol efflux. Curr. Opin. Lipidol. 21:167-71
109. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, et al. 2003. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422:83-87 (Pubitemid 36323300)
110. WanG, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, HuCA. 2008. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J. Biol. Chem. 283:21540-49
111. Wang N, Lan D, ChenW, Matsuura F, Tall AR. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101:9774-79 (Pubitemid 38869312)
112. WangX, CollinsHL, RanallettaM, Fuki IV, Billheimer JT, et al. 2007. MacrophageABCA1andABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117:2216-24 (Pubitemid 47219566)
113. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G. 2009. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J. Lipid Res. 50:574-85
114. Wilhelm AJ, ZabalawiM, Grayson JM, Weant AE, Major AS, et al. 2009. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler. Thromb. Vasc. Biol. 29:843-49
115. Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, et al. 2010. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/-mice. J. Biol. Chem. 285:36158-69
116. Wolfrum C, Poy MN, Stoffel M. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11:418-22 (Pubitemid 40562332)
117. Xu N, Dahlback B. 1999. A novel human apolipoprotein (apoM). J. Biol. Chem. 274:31286-90
118. Yancey PG, Bortnick AE, Kellner-Weibel G, Llera-MoyaM, PhillipsMC, Rothblat GH. 2003. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23:712-19 (Pubitemid 36566157)
119. Yancey PG, Llera-Moya M, Swarnakar S, Monzo P, Klein SM, et al. 2000. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275:36596-604 (Pubitemid 32002059)
120. Yin K, Deng X, Mo ZC, Zhao GJ, Jiang J, et al. 2011. Tristetraprolin- dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I. J. Biol. Chem. 286:13834-45
121. Youm Y-H, Kanneganti T-D, Vandanmagsar B, Zhu X, Ravussin A, et al. 2012. The NLRP3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep. 1:56-68
122. Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, et al. 2001. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7:853-57 (Pubitemid 32691642)
123. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, et al. 2010. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328:1689-93
124. Yvan-Charvet L, Ranalletta M, Wang N, Han S, Terasaka N, et al. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117:3900-8 (Pubitemid 350224099)
125. Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, et al. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118:1837-47
126. Zelcer N, Hong C, Boyadjian R, Tontonoz P. 2009. LXR regulates cholesterol uptake through Idoldependent ubiquitination of the LDL receptor. Science 325:100-4
127. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. 2005. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115:2870-74 (Pubitemid 41434414)
128. Zhu X, Lee JY, Timmins JM, Brown JM, Boudyguina E, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283:22930-41
129. Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, et al. 2010. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 51:3196-206